Unknown

Dataset Information

0

APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase.


ABSTRACT: The low-molecular-weight compound APR-246 (PRIMA-1(MET)) restores wild-type conformation and function to mutant p53, and triggers apoptosis in tumor cells. We show here that APR-246 also targets the selenoprotein thioredoxin reductase 1 (TrxR1), a key regulator of cellular redox balance. APR-246 inhibited both recombinant TrxR1 in vitro and TrxR1 in cells. A Sec-to-Cys mutant of TrxR1 was not inhibited by APR-246, suggesting targeting of the selenocysteine residue in wild-type TrxR1. Preheated APR-246 and its conversion product methylene quinuclidinone (MQ) were much more efficient TrxR1 inhibitors than APR-246 itself, indicating that MQ is the active compound responsible for TrxR1 enzyme inhibition. TrxR1 inhibited by MQ was still functional as a pro-oxidant NADPH oxidase. Knockdown of TrxR1 caused a partial and reproducible attenuation of APR-246-induced tumor cell death independently of p53 status. Cellular TrxR1 activity was also inhibited by APR-246 irrespective of p53 status. We show that APR-246 can directly affect cellular redox status via targeting of TrxR1. Our findings provide an explanation for the previously observed effects of APR-246 on tumor cells lacking mutant p53.

SUBMITTER: Peng X 

PROVIDER: S-EPMC3920950 | biostudies-other | 2013

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC2898413 | biostudies-literature
| S-EPMC6107631 | biostudies-literature
| S-EPMC8564101 | biostudies-literature
| S-EPMC3792407 | biostudies-literature
| S-EPMC2733882 | biostudies-literature
| S-EPMC3704198 | biostudies-literature
| S-EPMC3459921 | biostudies-literature
| S-EPMC2690020 | biostudies-literature
| S-EPMC6850073 | biostudies-literature
| S-EPMC5788606 | biostudies-literature